Science:Life Sciences
Tuberculosis (TB) is a bacterial infectious disease that affects millions of people globally every year. Despite being one of the oldest infectious diseases in humans, control of the epidemic through treatment and vaccination has remained out of reach. In today’s episode, we learned about what makes TB so difficult to control, from immunology to stigma. First, Dr. Jun Liu, a Professor in the Department of Molecular Genetics at University of Toronto, guides us through current knowledge on TB and discusses the difficulties and advances in developing TB vaccines. Next, Dr. Amrita Daftary, a Professor in the Department of Global Health at York University, explains the process of diagnosing and treating TB, and later highlights challenges that patients with TB may face while accessing care. Finally, Dr. Sarah Fortune, the Director of TB Research Program at Harvard T. H. Chan School of Public Health, helps us understand how TB drug resistance can arise, and why TB-HIV co-infection poses such a challenge. The fight against TB continues every day, by millions of patients, healthcare providers, and researchers alike. Join us as we learn about this forgotten pandemic.
Written by: Tsukiko Miyata
Dr. Jun Liu - profile
Dr. Amrita Daftary - profile
Dr. Sarah Fortune - profile
What is DOTS? - report
Paul Farmer on Partners in Health, Harvard-Haiti, and making the lives of the poor the fight of his life
TB Personal Stories
Vaccine Preventable Diseases
More Episodes
2022-04-04
935
2022-03-03
914
2022-02-26
776
2022-02-02
1.1k
2021-12-08
1.4k
2021-11-10
1.2k
2021-10-27
1,000
2021-10-13
1.2k
2021-09-29
894
2021-09-15
1.2k
2021-04-26
699
2021-04-07
392
2021-03-24
273
2021-03-10
326
2021-02-24
856
2021-02-10
429
2021-01-27
219
2020-12-17
205
Get this podcast on your
phone, FREE
